Skip to main content
. 2016 Sep 30;44(21):10277–10291. doi: 10.1093/nar/gkw844

Figure 5.

Figure 5.

(A) Alveolar development is dependent on the Stat5 autoregulatory enhancer. Histologically mammary tissue appeared normal in the presence of only one intact Stat5 allele (Stat5+/−). Mammary tissue with homozygous deletion of the autoregulatory enhancer (Stat5ΔE/ΔE) appeared less differentiated and Stat5ΔE/− was severely underdeveloped. (B) Qualitatively, pSTAT5 staining of wild-type (Stat5+/+) tissue appeared similar to Stat5+/−. In contrast, pSTAT5 staining was greatly reduced in Stat5ΔE/ΔE, Stat5ΔE/− tissues. (C) Stat5a mRNA levels in wild-type and mutant mammary tissue (Stat5+/+ n = 6; Stat5+/- n = 2; Stat5ΔE/ΔE n = 4; Stat5ΔE/− n = 3). (D) The Western blot showed reduced STAT5 levels in Stat5ΔE/ΔE tissue. GAPDH served as control, and showed no reduction. (E) Peak coverage in wild-type and mutant tissue. (F) STAT5A enhancers were reduced in Stat5+/− tissue and completely absent in Stat5ΔE/ΔE and Stat5ΔE/− tissue. Reduction of H3K27ac was delayed in all genotypes except Stat5ΔE/− where it was absent. (G) Representative genes with class 1, class 2 and class 3 enhancers. STAT5 binding in mutant tissue was most severely affected in class 1 enhancers (Glycam1) and the least in class 3 enhancers (Bcl6).